Advertisement

Cell therapies for Chagas disease

  • Adriana Bastos Carvalho
    Affiliations
    Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

    Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

    Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, Rio de Janeiro, Brazil
    Search for articles by this author
  • Regina Coeli Dos Santos Goldenberg
    Affiliations
    Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

    Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

    Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, Rio de Janeiro, Brazil
    Search for articles by this author
  • Antonio Carlos Campos de Carvalho
    Correspondence
    Correspondence: Antonio Carlos Campos de Carvalho, MD, PhD, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho 373 Bloco G, Sala G2-053, Rio de Janeiro, CEP 21941-902, Brazil.
    Affiliations
    Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

    Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

    Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, Rio de Janeiro, Brazil
    Search for articles by this author
Published:September 05, 2017DOI:https://doi.org/10.1016/j.jcyt.2017.07.014

      Abstract

      In this review of cell therapies in Chagas disease, we cover aspects related to the disease, its treatment and world demographics, before proceeding to describe the preclinical and clinical trials performed using cell therapies in the search for an alternative therapy for the most severe and lethal form of this disease, chronic chagasic cardiomyopathy.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rassi Jr, A.
        • Rassi A.
        • Marin-Neto J.A.
        Chagas disease.
        Lancet. 2010; 375: 1388-1402
        • Ribeiro A.L.
        • Nunes M.P.
        • Teixeira M.M.
        • Rocha M.O.
        Diagnosis and management of Chagas disease and cardiomyopathy.
        Nat Rev Cardiol. 2012; 9: 576-589
        • Bern C.
        Chagas' disease.
        N Engl J Med. 2015; 373: 456-466
        • Andrade J.P.
        • Marin Neto J.A.
        • Paola A.A.
        • Vilas-Boas F.
        • Oliveira G.M.
        • Bacal F.
        • et al.
        I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary.
        Arq Bras Cardiol. 2011; 96: 434-442
        • Bern C.
        Antitrypanosomal therapy for chronic Chagas' disease.
        N Engl J Med. 2011; 364: 2527-2534
        • de Andrade A.L.
        • Zicker F.
        • de Oliveira R.M.
        • Almeida Silva S.
        • Luquetti A.
        • Travassos L.R.
        • et al.
        Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.
        Lancet. 1996; 348: 1407-1413
        • Andrade A.L.
        • Martelli C.M.
        • Oliveira R.M.
        • Silva S.A.
        • Aires A.I.
        • Soussumi L.M.
        • et al.
        Short report: benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up.
        Am J Trop Med Hyg. 2004; 71: 594-597
        • Sosa Estani S.
        • Segura E.L.
        • Ruiz A.M.
        • Velazquez E.
        • Porcel B.M.
        • Yampotis C.
        Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease.
        Am J Trop Med Hyg. 1998; 59: 526-529
        • Morillo C.A.
        • Marin-Neto J.A.
        • Avezum A.
        • Sosa-Estani S.
        • Rassi Jr, A.
        • Rosas F.
        • et al.
        Randomized trial of benznidazole for chronic Chagas' cardiomyopathy.
        N Engl J Med. 2015; 373: 1295-1306
      1. Chagas disease in Latin America: an epidemiological update based on 2010 estimates.
        Wkly Epidemiol Rec. 2015; 90: 33-43
        • Dias J.C.
        • Silveira A.C.
        • Schofield C.J.
        The impact of Chagas disease control in Latin America: a review.
        Mem Inst Oswaldo Cruz. 2002; 97: 603-612
        • Lee B.Y.
        • Bacon K.M.
        • Bottazzi M.E.
        • Hotez P.J.
        Global economic burden of Chagas disease: a computational simulation model.
        Lancet Infect Dis. 2013; 13: 342-348
        • Murray C.J.
        • Vos T.
        • Lozano R.
        • Naghavi M.
        • Flaxman A.D.
        • Michaud C.
        • et al.
        Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010.
        Lancet. 2012; 380: 2197-2223
        • Orlic D.
        • Kajstura J.
        • Chimenti S.
        • Jakoniuk I.
        • Anderson S.M.
        • Li B.
        • et al.
        Bone marrow cells regenerate infarcted myocardium.
        Nature. 2001; 410: 701-705
        • Meyer G.P.
        • Wollert K.C.
        • Lotz J.
        • Steffens J.
        • Lippolt P.
        • Fichtner S.
        • et al.
        Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
        Circulation. 2006; 113: 1287-1294
        • Schachinger V.
        • Erbs S.
        • Elsasser A.
        • Haberbosch W.
        • Hambrecht R.
        • Holschermann H.
        • et al.
        Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.
        N Engl J Med. 2006; 355: 1210-1221
        • Vilar-Pereira G.
        • Carneiro V.C.
        • Mata-Santos H.
        • Vicentino A.R.
        • Ramos I.P.
        • Giarola N.L.
        • et al.
        Resveratrol reverses functional Chagas heart disease in mice.
        PLoS Pathog. 2016; 12: e1005947
        • Goldenberg R.C.
        • Jelicks L.A.
        • Fortes F.S.
        • Weiss L.M.
        • Rocha L.L.
        • Zhao D.
        • et al.
        Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model.
        J Infect Dis. 2008; 197: 544-547
        • de Souza A.P.
        • Tang B.
        • Tanowitz H.B.
        • Araujo-Jorge T.C.
        • Jelicks E.L.
        Magnetic resonance imaging in experimental Chagas disease: a brief review of the utility of the method for monitoring right ventricular chamber dilatation.
        Parasitol Res. 2005; 97: 87-90
        • Eickhoff C.S.
        • Lawrence C.T.
        • Sagartz J.E.
        • Bryant L.A.
        • Labovitz A.J.
        • Gala S.S.
        • et al.
        ECG detection of murine chagasic cardiomyopathy.
        J Parasitol. 2010; 96: 758-764
        • Garg N.
        • Gerstner A.
        • Bhatia V.
        • DeFord J.
        • Papaconstantinou J.
        Gene expression analysis in mitochondria from chagasic mice: alterations in specific metabolic pathways.
        Biochem J. 2004; 381: 743-752
        • Mukherjee S.
        • Belbin T.J.
        • Spray D.C.
        • Iacobas D.A.
        • Weiss L.M.
        • Kitsis R.N.
        • et al.
        Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy.
        Parasitol Res. 2003; 91: 187-196
        • Mukherjee S.
        • Nagajyothi F.
        • Mukhopadhyay A.
        • Machado F.S.
        • Belbin T.J.
        • Campos de Carvalho A.
        • et al.
        Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection.
        Genomics. 2008; 91: 423-432
        • Soares M.B.
        • de Lima R.S.
        • Rocha L.L.
        • Vasconcelos J.F.
        • Rogatto S.R.
        • dos Santos R.R.
        • et al.
        Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy.
        J Infect Dis. 2010; 202: 416-426
        • Lewis M.D.
        • Fortes Francisco A.
        • Taylor M.C.
        • Burrell-Saward H.
        • McLatchie A.P.
        • Miles M.A.
        • et al.
        Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection.
        Cell Microbiol. 2014; 16: 1285-1300
        • Soares M.B.
        • Lima R.S.
        • Rocha L.L.
        • Takyia C.M.
        • Pontes-de-Carvalho L.
        • de Carvalho A.C.
        • et al.
        Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice.
        Am J Pathol. 2004; 164: 441-447
        • Souza B.S.
        • Azevedo C.M.
        • d Lima R.S.
        • Kaneto C.M.
        • Vasconcelos J.F.
        • Guimaraes E.T.
        • et al.
        Bone marrow cells migrate to the heart and skeletal muscle and participate in tissue repair after Trypanosoma cruzi infection in mice.
        Int J Exp Pathol. 2014; 95: 321-329
        • Soares M.B.
        • Lima R.S.
        • Souza B.S.
        • Vasconcelos J.F.
        • Rocha L.L.
        • Dos Santos R.R.
        • et al.
        Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells.
        Cell Cycle. 2011; 10: 1448-1455
        • Macambira S.G.
        • Vasconcelos J.F.
        • Costa C.R.
        • Klein W.
        • Lima R.S.
        • Guimaraes P.
        • et al.
        Granulocyte colony-stimulating factor treatment in chronic Chagas disease: preservation and improvement of cardiac structure and function.
        FASEB J. 2009; 23: 3843-3850
        • Vasconcelos J.F.
        • Souza B.S.
        • Lins T.F.
        • Garcia L.M.
        • Kaneto C.M.
        • Sampaio G.P.
        • et al.
        Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy.
        FASEB J. 2013; 27: 4691-4702
        • Le Blanc K.
        Mesenchymal stromal cells: tissue repair and immune modulation.
        Cytotherapy. 2006; 8: 559-561
        • Williams A.R.
        • Hare J.M.
        Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease.
        Circ Res. 2011; 109: 923-940
        • Jasmin
        • Jelicks L.A.
        • Koba W.
        • Tanowitz H.B.
        • Mendez-Otero R.
        • Campos de Carvalho A.C.
        • et al.
        Mesenchymal bone marrow cell therapy in a mouse model of chagas disease. Where do the cells go?.
        PLoS Negl Trop Dis. 2012; 6: e1971
        • Jasmin
        • Jelicks L.A.
        • Tanowitz H.B.
        • Peters V.M.
        • Mendez-Otero R.
        • Campos de Carvalho A.C.
        • et al.
        Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease.
        Microbes Infect. 2014; 16: 923-935
        • Mello D.B.
        • Ramos I.P.
        • Mesquita F.C.
        • Brasil G.V.
        • Rocha N.N.
        • Takiya C.M.
        • et al.
        Adipose tissue-derived mesenchymal stromal cells protect mice infected with trypanosoma cruzi from cardiac damage through modulation of anti-parasite immunity.
        PLoS Negl Trop Dis. 2015; 9: e0003945
        • Larocca T.F.
        • Souza B.S.
        • Silva C.A.
        • Kaneto C.M.
        • Alcantara A.C.
        • Azevedo C.M.
        • et al.
        Transplantation of adipose tissue mesenchymal stem cells in experimental chronic chagasic cardiopathy.
        Arq Bras Cardiol. 2013; 100: 460-468
        • Vilas-Boas F.
        • Feitosa G.S.
        • Soares M.B.
        • Pinho-Filho J.A.
        • Mota A.
        • Almeida A.J.
        • et al.
        Bone marrow cell transplantation to the myocardium of a patient with heart failure due to Chagas' disease.
        Arq Bras Cardiol. 2004; 82 (181-4): 185-187
        • Vilas-Boas F.
        • Feitosa G.S.
        • Soares M.B.
        • Mota A.
        • Pinho-Filho J.A.
        • Almeida A.J.
        • et al.
        Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease].
        Arq Bras Cardiol. 2006; 87: 159-166
        • Vilas-Boas F.
        • Feitosa G.S.
        • Soares M.B.
        • Pinho-Filho J.A.
        • Mota A.C.
        • Almeida A.J.
        • et al.
        Bone marrow cell transplantation in Chagas' disease heart failure: report of the first human experience.
        Arq Bras Cardiol. 2011; 96: 325-331
        • Barbosa da Fonseca L.M.
        • Xavier S.S.
        • Rosado de Castro P.H.
        • Lima R.S.
        • Gutfilen B.
        • Goldenberg R.C.
        • et al.
        Biodistribution of bone marrow mononuclear cells in chronic chagasic cardiomyopathy after intracoronary injection.
        Int J Cardiol. 2011; 149: 310-314
        • Tura B.R.
        • Martino H.F.
        • Gowdak L.H.
        • dos Santos R.R.
        • Dohmann H.F.
        • Krieger J.E.
        • et al.
        Multicenter randomized trial of cell therapy in cardiopathies—MiHeart Study.
        Trials. 2007; 8: 2
        • Ribeiro Dos Santos R.
        • Rassi S.
        • Feitosa G.
        • Grecco O.T.
        • Rassi Jr, A.
        • da Cunha A.B.
        • et al.
        Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial.
        Circulation. 2012; 125: 2454-2461
        • Perel P.
        • Roberts I.
        • Sena E.
        • Wheble P.
        • Briscoe C.
        • Sandercock P.
        • et al.
        Comparison of treatment effects between animal experiments and clinical trials: systematic review.
        BMJ. 2007; 334: 197
        • Uygur A.
        • Lee R.T.
        Mechanisms of cardiac regeneration.
        Dev Cell. 2016; 36: 362-374
        • Bergmann O.
        • Bhardwaj R.D.
        • Bernard S.
        • Zdunek S.
        • Barnabe-Heider F.
        • Walsh S.
        • et al.
        Evidence for cardiomyocyte renewal in humans.
        Science. 2009; 324: 98-102
        • Porrello E.R.
        • Johnson B.A.
        • Aurora A.B.
        • Simpson E.
        • Nam Y.J.
        • Matkovich S.J.
        • et al.
        MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes.
        Circ Res. 2011; 109: 670-679
        • Porrello E.R.
        • Mahmoud A.I.
        • Simpson E.
        • Johnson B.A.
        • Grinsfelder D.
        • Canseco D.
        • et al.
        Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family.
        Proc Natl Acad Sci USA. 2013; 110: 187-192
        • Silva D.N.
        • de Freitas Souza B.S.
        • Azevedo C.M.
        • Vasconcelos J.F.
        • Carvalho R.H.
        • Soares M.B.
        • et al.
        Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy.
        Stem Cell Res Ther. 2014; 5: 81
        • Menasche P.
        • Vanneaux V.
        • Hagege A.
        • Bel A.
        • Cholley B.
        • Cacciapuoti I.
        • et al.
        Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report.
        Eur Heart J. 2015; 36: 2011-2017
        • Santos F.M.
        • Lima W.G.
        • Gravel A.S.
        • Martins T.A.
        • Talvani A.
        • Torres R.M.
        • et al.
        Cardiomyopathy prognosis after benznidazole treatment in chronic canine Chagas' disease.
        J Antimicrob Chemother. 2012; 67: 1987-1995